With the ability to fabricate small batches of precise structures and personalised dosage rapidly, pharmaceutical 3D printing makes personalised medicine safer and more accessible. It also has the ability to drastically improve patient treatment adherence, with personalised colour, flavour, shape and drug combinations (polypills). This technology is now being analysed for different drugs in clinical studies across the world. This presentation will provide an overview of the field and discuss exciting recent updates, including clinical studies, regulatory updates and how to get involved.
The speaker is:
Dr. Anna Worsley, Director of Innovation, FABRX
Tags
- Pharmazie